We use our own and third party cookies to offer you our services, customize and analyze your browsing and show you advertising related to your preferences. By continuing to browse, we consider that you accept its use. You can change the settings and get more information in the
One of the most recent lines of investigation focuses on identifying each tumour’s genetic and molecular characteristics with increasingly greater accuracy. In other words, the aim is to characterise each individual tumour in as much detail as possible so treatment can be personalised to each patient, a methodology that has proven more effective than conventional ones. It is a very complex and expensive field of research but it is gradually offering better results.
Besides the tumour’s characteristics, another very important factor in the development of brain tumour treatments is the creation of techniques that, as far as possible, only target a specific type of tumour. These revolve around medicines designed to attack a specific tumour factor or the combined use of several different drugs.
Therapies designed to modify the body’s own defence system so that it may attack and eliminate the tumour are also being developed. This is a very promising treatment line known as immunotherapy.